Full Text
When can pharmaceutical companies communicate health economic claims to payers? 10 case studies

Abstract

Authors

P.J. Neumann C.J. Saret

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×